J. Whitaker
Chief Tech/Sci/R&D Officer bei OMEROS CORPORATION
Profil
J.
Steven Whitaker is currently the Vice President-Clinical Development at Omeros Corp.
He previously worked as the Divisional Vice President at ICOS Corp from 1994 to 2007 and as the Chief Medical Officer & VP-Clinical Development at Allon Therapeutics, Inc. from 2008 to 2010.
Whitaker holds a graduate degree from the University of Washington, an undergraduate degree from Butler University, and a doctorate degree from The Indiana University School of Medicine.
Aktive Positionen von J. Whitaker
| Unternehmen | Position | Beginn |
|---|---|---|
| OMEROS CORPORATION | Chief Tech/Sci/R&D Officer | 01.11.2019 |
Ehemalige bekannte Positionen von J. Whitaker
| Unternehmen | Position | Ende |
|---|---|---|
| ALLON THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01.03.2010 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01.05.2007 |
Ausbildung von J. Whitaker
| University of Washington | Graduate Degree |
| Butler University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OMEROS CORPORATION | Health Technology |
| ALLON THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
